Case Report
BibTex RIS Cite

Retroperitoneal Leiomyosarkom

Year 2016, Volume: 1 Issue: 3, 134 - 136, 05.10.2017

Abstract




Leiomyosarkom retroperitondaki düz kas hücrelerinden çıkabilen nadir bir malign tümördür. Tüm yumuşak doku sarkomlarının yaklaşık %5-10 kadarını leiomyosarkomlar oluşturur. Tanı konulmadan önce sıklıkla büyük boyutlara ulaşır. Bu yazıda çok nadir olarak görülen retroperitoneal leimyosarkomlu 61 yaşındaki kadın hastayı klinik ve mikroskopik


bulgulularla sunduk.



References

  • 1. Gustafson P, Willen H, Baldetrop B Fernö M, Akerman M, Rydholm A.Soft tissue leimyosarcoma: a population based epidemiologic and prognestic study of 48 patients, including cellular DNA content. Cancer 1992 ;70: 114-9. 2. Ardoino I, Miceli R, Berselli M. Biganzoli E, Fiore M, Collini P, Stacchiotti S, Casali PG, Gronchi A. Histology spesific nomogram for primary retroperitoneal soft tissue srcoma. Cancer 2010;116:2429-36.
  • 3. Campell-Walsh Üroloji, 2014; 4.cilt: üst üriner sistem kanserleri, Kısım 12, 1508.
  • 4. Hueman MT, Herman JM, Ahuja N. Management of retroperitoneal sarcomas. Surg Clin North Am. 2008;88:583-97.
  • 5. Gronchi A, Casali PG, Fiore M, Mariani L, Lo Vullo S, Bertulli R, Colecchia M, Lozza L, Olmi P, Santinami M, Rosai J. Retroperitoneal soft tissue srcoma; pattern of recurrence in 167 patients treated at a single institution. Cancer 2004;100:2448-55.
  • 6. Bautista N, Su W, O’Connell T. Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease. Am Surg. 2000 Sep;66(9):832-6.
  • 7. Stoeckle E, Coindre JM, Bonvalot S, Kantor G, Terrier P, Bonichon F, Nguyen Bui B; French Federation of Cancer Centers Sarcoma Group. Prognostic factors in retroperitoneal sarcomas; a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92:359-68.

Retroperitoneal Leiomyosarcoma

Year 2016, Volume: 1 Issue: 3, 134 - 136, 05.10.2017

Abstract

Leiomyosarcoma a rare malignancy of smooth muscle may arise from the retroperitoneum. Of all soft tissue sarcomas approximately 5-10% are leiomyosarcomas. They often reach a large size before diagnosis is made. We present a 61 year old female patient with retroperitoneal leiomyosarcoma who was seen very rarely in this article with clinical and microscopic findings.
















 

References

  • 1. Gustafson P, Willen H, Baldetrop B Fernö M, Akerman M, Rydholm A.Soft tissue leimyosarcoma: a population based epidemiologic and prognestic study of 48 patients, including cellular DNA content. Cancer 1992 ;70: 114-9. 2. Ardoino I, Miceli R, Berselli M. Biganzoli E, Fiore M, Collini P, Stacchiotti S, Casali PG, Gronchi A. Histology spesific nomogram for primary retroperitoneal soft tissue srcoma. Cancer 2010;116:2429-36.
  • 3. Campell-Walsh Üroloji, 2014; 4.cilt: üst üriner sistem kanserleri, Kısım 12, 1508.
  • 4. Hueman MT, Herman JM, Ahuja N. Management of retroperitoneal sarcomas. Surg Clin North Am. 2008;88:583-97.
  • 5. Gronchi A, Casali PG, Fiore M, Mariani L, Lo Vullo S, Bertulli R, Colecchia M, Lozza L, Olmi P, Santinami M, Rosai J. Retroperitoneal soft tissue srcoma; pattern of recurrence in 167 patients treated at a single institution. Cancer 2004;100:2448-55.
  • 6. Bautista N, Su W, O’Connell T. Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease. Am Surg. 2000 Sep;66(9):832-6.
  • 7. Stoeckle E, Coindre JM, Bonvalot S, Kantor G, Terrier P, Bonichon F, Nguyen Bui B; French Federation of Cancer Centers Sarcoma Group. Prognostic factors in retroperitoneal sarcomas; a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92:359-68.
There are 6 citations in total.

Details

Primary Language Turkish
Journal Section Case report
Authors

Mustafa Yordam

Çağrı Şenocak This is me

Mehmet Çiftçi This is me

Görkem Güvenir This is me

Gülçin Güler Şimşek This is me

Ömer Faruk Bozkurt

Publication Date October 5, 2017
Published in Issue Year 2016 Volume: 1 Issue: 3

Cite

APA Yordam, M., Şenocak, Ç., Çiftçi, M., Güvenir, G., et al. (2017). Retroperitoneal Leiomyosarkom. Akademik Araştırma Tıp Dergisi, 1(3), 134-136.
AMA Yordam M, Şenocak Ç, Çiftçi M, Güvenir G, Şimşek GG, Bozkurt ÖF. Retroperitoneal Leiomyosarkom. AATD. October 2017;1(3):134-136.
Chicago Yordam, Mustafa, Çağrı Şenocak, Mehmet Çiftçi, Görkem Güvenir, Şimşek Gülçin Güler, and Ömer Faruk Bozkurt. “Retroperitoneal Leiomyosarkom”. Akademik Araştırma Tıp Dergisi 1, no. 3 (October 2017): 134-36.
EndNote Yordam M, Şenocak Ç, Çiftçi M, Güvenir G, Şimşek GG, Bozkurt ÖF (October 1, 2017) Retroperitoneal Leiomyosarkom. Akademik Araştırma Tıp Dergisi 1 3 134–136.
IEEE M. Yordam, Ç. Şenocak, M. Çiftçi, G. Güvenir, G. G. Şimşek, and Ö. F. Bozkurt, “Retroperitoneal Leiomyosarkom”, AATD, vol. 1, no. 3, pp. 134–136, 2017.
ISNAD Yordam, Mustafa et al. “Retroperitoneal Leiomyosarkom”. Akademik Araştırma Tıp Dergisi 1/3 (October 2017), 134-136.
JAMA Yordam M, Şenocak Ç, Çiftçi M, Güvenir G, Şimşek GG, Bozkurt ÖF. Retroperitoneal Leiomyosarkom. AATD. 2017;1:134–136.
MLA Yordam, Mustafa et al. “Retroperitoneal Leiomyosarkom”. Akademik Araştırma Tıp Dergisi, vol. 1, no. 3, 2017, pp. 134-6.
Vancouver Yordam M, Şenocak Ç, Çiftçi M, Güvenir G, Şimşek GG, Bozkurt ÖF. Retroperitoneal Leiomyosarkom. AATD. 2017;1(3):134-6.